Loading
Latest filing published 18 Nov 2013 for ROCHESTER MEDICAL CORPORATION.
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
Sarah L. Grinde is a declared insider of Rochester Medical Corporation, with filings sourced from SEC (Form 4). We count 4 filings; the first trade dates from 12 December 2012 and the latest from 14 November 2013.
No open-market sale appears; the market trades are 1 purchase worth €3,804. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 2 share grants.
The latest filing, published on 18 November 2013, reports a share grant in Rochester Medical Corporation. The most recent open-market purchase was published on 14 December 2012, 5,061 days ago. Typically, a trade is published a median of 4 days after it takes place. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations